Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
8GSI
DownloadVisualize
BU of 8gsi by Molmil
Structure of the cobolimab Fab
Descriptor: heavy chain, light chain, nanobody
Authors:Heo, Y.S, Choi, S.B.
Deposit date:2022-09-06
Release date:2023-09-06
Method:X-RAY DIFFRACTION (2.02 Å)
Cite:Crystal structure of the Fab fragment of cobolimab, an investigational antibody targeting Tim-3 for immune-oncology.
To Be Published
7VEN
DownloadVisualize
BU of 7ven by Molmil
Structure of burosumab Fab
Descriptor: Burosumab Fab HC, Burosumab Fab LC
Authors:Heo, Y.S.
Deposit date:2021-09-09
Release date:2022-09-14
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (1.45 Å)
Cite:Crystal Structure of the Fab Fragment of Burosumab
To Be Published
6JC2
DownloadVisualize
BU of 6jc2 by Molmil
Crystal structure of the Fab fragment of ipilimumab
Descriptor: SULFATE ION, ipilimumab fab heavy chain, ipilimumab fab light chain
Authors:Heo, Y.S.
Deposit date:2019-01-27
Release date:2019-09-11
Method:X-RAY DIFFRACTION (2.65 Å)
Cite:Crystal Structure of the Fab Fragment of an Anti-CTLA-4 Antibody, Ipilimumab, Used for Cancer Immunotherapy
Bull.Korean Chem.Soc., 40, 2019
4HQ6
DownloadVisualize
BU of 4hq6 by Molmil
BC domain in the presence of citrate
Descriptor: Acetyl-CoA carboxylase 2
Authors:Heo, Y.S.
Deposit date:2012-10-25
Release date:2013-10-09
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.7 Å)
Cite:Structural Insights into the Regulation of ACC2 by Citrate
Bull.Korean Chem.Soc., 34, 2013
7BXA
DownloadVisualize
BU of 7bxa by Molmil
Crystal structure of PD-1 in complex with tislelizumab Fab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S, Lee, S.H, Lim, H, Lee, H.T, Kim, Y.J, Park, E.B.
Deposit date:2020-04-18
Release date:2020-06-10
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (3.32 Å)
Cite:Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy.
Biochem.Biophys.Res.Commun., 527, 2020
5GGU
DownloadVisualize
BU of 5ggu by Molmil
Crystal structure of tremelimumab Fab
Descriptor: heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (2.292 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGS
DownloadVisualize
BU of 5ggs by Molmil
PD-1 in complex with pembrolizumab Fab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.997 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGV
DownloadVisualize
BU of 5ggv by Molmil
CTLA-4 in complex with tremelimumab Fab
Descriptor: Cytotoxic T-lymphocyte protein 4, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.998 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGT
DownloadVisualize
BU of 5ggt by Molmil
PD-L1 in complex with BMS-936559 Fab
Descriptor: IGK@ protein, IgG H chain, Programmed cell death 1 ligand 1
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.8 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGR
DownloadVisualize
BU of 5ggr by Molmil
PD-1 in complex with nivolumab Fab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (3.3 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGQ
DownloadVisualize
BU of 5ggq by Molmil
Crystal structure of Nivolumab Fab fragment
Descriptor: nivolumab heavy chain, nivolumab light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
3LPX
DownloadVisualize
BU of 3lpx by Molmil
Crystal structure of GyrA
Descriptor: DNA gyrase, A subunit
Authors:Jung, H.Y, Heo, Y.S.
Deposit date:2010-02-07
Release date:2011-02-16
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.6 Å)
Cite:Crystal structure of GyrA
To be Published
7WSL
DownloadVisualize
BU of 7wsl by Molmil
PD-1 in complex with Dostarlimab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2022-01-30
Release date:2022-08-24
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (1.534 Å)
Cite:Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy.
Biochem.Biophys.Res.Commun., 599, 2022
5WUX
DownloadVisualize
BU of 5wux by Molmil
TNFalpha-certolizumab Fab
Descriptor: Tumor necrosis factor alpha, heavy, light
Authors:Heo, Y.S, Lee, J.U.
Deposit date:2016-12-21
Release date:2017-06-07
Method:X-RAY DIFFRACTION (2.9 Å)
Cite:Molecular Basis for the Neutralization of Tumor Necrosis Factor alpha by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
Int J Mol Sci, 18, 2017
5WUV
DownloadVisualize
BU of 5wuv by Molmil
Crystal structure of Certolizumab Fab
Descriptor: heavy chain, light chain
Authors:Heo, Y.S, Lee, J.U, Son, J.Y, Shin, W, Yoo, K.Y.
Deposit date:2016-12-21
Release date:2017-06-07
Method:X-RAY DIFFRACTION (1.952 Å)
Cite:Molecular Basis for the Neutralization of Tumor Necrosis Factor alpha by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
Int J Mol Sci, 18, 2017
5X8M
DownloadVisualize
BU of 5x8m by Molmil
PD-L1 in complex with durvalumab
Descriptor: Programmed cell death 1 ligand 1, durvalumab heavy chain, durvalumab light chain
Authors:Heo, Y.S, Lee, H.T.
Deposit date:2017-03-03
Release date:2017-08-16
Method:X-RAY DIFFRACTION (2.661 Å)
Cite:Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
Sci Rep, 7, 2017
5X8L
DownloadVisualize
BU of 5x8l by Molmil
PD-L1 in complex with atezolizumab
Descriptor: Programmed cell death 1 ligand 1, atezolizumab heavy chain, atezolizumab light chain
Authors:Heo, Y.S, Lee, H.T.
Deposit date:2017-03-03
Release date:2017-08-16
Method:X-RAY DIFFRACTION (3.1 Å)
Cite:Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
Sci Rep, 7, 2017
2HJW
DownloadVisualize
BU of 2hjw by Molmil
Crystal Structure of the BC domain of ACC2
Descriptor: Acetyl-CoA carboxylase 2
Authors:Cho, Y.S, Lee, J.I, Shin, D, Kim, H.T, Lee, T.G, Heo, Y.S.
Deposit date:2006-07-02
Release date:2007-07-03
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:Crystal structure of the biotin carboxylase domain of human acetyl-CoA carboxylase 2.
Proteins, 70, 2008
2O5K
DownloadVisualize
BU of 2o5k by Molmil
Crystal Structure of GSK3beta in complex with a benzoimidazol inhibitor
Descriptor: 2-(2,4-DICHLORO-PHENYL)-7-HYDROXY-1H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID [2-(4-METHANESULFONYLAMINO-PHENYL)-ETHYL]-AMIDE, Glycogen synthase kinase-3 beta
Authors:Shin, D, Lee, S.C, Heo, Y.S, Cho, Y.S, Kim, Y.E, Hyun, Y.L, Cho, J.M, Lee, Y.S, Ro, S.
Deposit date:2006-12-06
Release date:2007-10-23
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (3.2 Å)
Cite:Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta
Bioorg.Med.Chem.Lett., 17, 2007
4Y7I
DownloadVisualize
BU of 4y7i by Molmil
Crystal Structure of MTMR8
Descriptor: Myotubularin-related protein 8, PHOSPHATE ION
Authors:Yoo, K, Lee, J, Son, J, Shin, W, Im, D, Heo, Y.S.
Deposit date:2015-02-15
Release date:2015-07-15
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.802 Å)
Cite:Structure of the catalytic phosphatase domain of MTMR8: implications for dimerization, membrane association and reversible oxidation.
Acta Crystallogr.,Sect.D, 71, 2015
3V3V
DownloadVisualize
BU of 3v3v by Molmil
Structural and functional analysis of quercetagetin, a natural JNK1 inhibitor
Descriptor: 3,5,6,7-TETRAHYDROXY-2-(3,4-DIHYDROXYPHENYL)-4H-CHROMEN-4-ONE, C-Jun-amino-terminal kinase-interacting protein 1, CHLORIDE ION, ...
Authors:Baek, S, Kang, N.J, Popowicz, G.M, Arciniega, M, Jung, S.K, Byun, S, Song, N.R, Heo, Y.S, Kim, B.Y, Lee, H.J, Holak, T.A, Augustin, M, Bode, A.M, Huber, R, Dong, Z, Lee, K.W.
Deposit date:2011-12-14
Release date:2012-12-05
Last modified:2023-09-13
Method:X-RAY DIFFRACTION (2.7 Å)
Cite:Structural and Functional Analysis of the Natural JNK1 Inhibitor Quercetagetin.
J.Mol.Biol., 425, 2013
3JRW
DownloadVisualize
BU of 3jrw by Molmil
Phosphorylated BC domain of ACC2
Descriptor: Acetyl-CoA carboxylase 2
Authors:Cho, Y.S, Lee, J.I, Shin, D, Kim, H.T, Lee, T.G, Heo, Y.S.
Deposit date:2009-09-09
Release date:2010-01-12
Last modified:2023-11-01
Method:X-RAY DIFFRACTION (2.6 Å)
Cite:Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK
Biochem.Biophys.Res.Commun., 391, 2010
3JRX
DownloadVisualize
BU of 3jrx by Molmil
Crystal structure of the BC domain of ACC2 in complex with soraphen A
Descriptor: Acetyl-CoA carboxylase 2, SORAPHEN A
Authors:Cho, Y.S, Lee, J.I, Shin, D, Kim, H.T, Lee, T.G, Heo, Y.S.
Deposit date:2009-09-09
Release date:2010-01-12
Last modified:2023-11-01
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK.
Biochem.Biophys.Res.Commun., 391, 2010
3NJ4
DownloadVisualize
BU of 3nj4 by Molmil
Fluoro-neplanocin A in Human S-Adenosylhomocysteine Hydrolase
Descriptor: (4S,5S)-4-(6-amino-9H-purin-9-yl)-3-fluoro-5-hydroxy-2-(hydroxymethyl)cyclopent-2-en-1-one, Adenosylhomocysteinase, NICOTINAMIDE-ADENINE-DINUCLEOTIDE
Authors:Jeong, L.S, Lee, K.M, Hwang, K.Y, Choi, S, Heo, Y.S.
Deposit date:2010-06-17
Release date:2011-05-04
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:X-ray crystal structure and binding mode analysis of human S-adenosylhomocysteine hydrolase complexed with novel mechanism-based inhibitors, haloneplanocin A analogues.
J.Med.Chem., 54, 2011
1L8O
DownloadVisualize
BU of 1l8o by Molmil
Molecular basis for the local conformational rearrangement of human phosphoserine phosphatase
Descriptor: L-3-phosphoserine phosphatase, PHOSPHATE ION, SERINE
Authors:Kim, H.Y, Heo, Y.S, Kim, J.H, Park, M.H, Moon, J, Park, S.Y, Lee, T.G, Jeon, Y.H, Ro, S, Hwang, K.Y.
Deposit date:2002-03-21
Release date:2003-04-01
Last modified:2021-11-10
Method:X-RAY DIFFRACTION (2.8 Å)
Cite:Molecular basis for the local conformational rearrangement of human phosphoserine phosphatase
J.Biol.Chem., 277, 2002

 

12>

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon